These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8347442)
41. [Nicorandil in the treatment of patients with ischemic heart disease]. Minushkina LO; Sidorenko BA Kardiologiia; 2013; 53(5):69-73. PubMed ID: 23952998 [TBL] [Abstract][Full Text] [Related]
42. [Drugs for angina pectoris]. Bloch R Cah Coll Med Hop Paris; 1966 Oct; 7(9):565-70. PubMed ID: 5976878 [No Abstract] [Full Text] [Related]
43. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways. Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012 [TBL] [Abstract][Full Text] [Related]
45. Nicorandil: a drug for many purposes: too good to be true? Eeckhout E Eur Heart J; 2003 Jul; 24(14):1282-4. PubMed ID: 12871683 [No Abstract] [Full Text] [Related]
46. [Effects of nicorandil on regional cerebral oxygen saturation]. Kasuya Y; Dohi S Masui; 1997 Oct; 46(10):1305-9. PubMed ID: 9369043 [TBL] [Abstract][Full Text] [Related]
47. [New data on the drug therapy of angina pectoris]. Urbaszek W Z Gesamte Inn Med; 1966 Nov; 21(21):641-9. PubMed ID: 5994727 [No Abstract] [Full Text] [Related]
48. Salvia miltiorrhiza and ischemic diseases. Ji XY; Tan BK; Zhu YZ Acta Pharmacol Sin; 2000 Dec; 21(12):1089-94. PubMed ID: 11603281 [TBL] [Abstract][Full Text] [Related]
49. Angina pectoris: a review of current and emerging therapies. Parker JO Am J Manag Care; 2004 Oct; 10(11 Suppl):S332-8. PubMed ID: 15603242 [TBL] [Abstract][Full Text] [Related]
51. Sinus arrest and severe peripheral vasodilation following cardiopulmonary bypass in a patient taking nicorandil. Montgomery H; Sumeray M; Carr C; Singer M Cardiovasc Drugs Ther; 1997 Mar; 11(1):81. PubMed ID: 9140682 [No Abstract] [Full Text] [Related]
52. Effects of a novel, selective and potent phosphodiesterase type V inhibitor, E4021, on myocardial ischemia in guinea pigs. Kodama K; Adachi H; Mori N; Saito I Eur J Pharmacol; 1994 Sep; 263(1-2):93-9. PubMed ID: 7821368 [TBL] [Abstract][Full Text] [Related]
54. Nicorandil related anal ulcer. Al-Hilli Z; Pritchard R; Roche-Nagle G; Deasy J; McNamara DA Ir J Med Sci; 2006; 175(3):62-3. PubMed ID: 17073250 [TBL] [Abstract][Full Text] [Related]
55. Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome. Morishita S; Maeba H; Takehana K; Shiojima I Intern Med; 2017 Sep; 56(17):2295-2299. PubMed ID: 28794372 [TBL] [Abstract][Full Text] [Related]
56. Clinical pharmacology of nicorandil in patients with congestive heart failure. Tice FD; Jungbluth GL; Binkley PF; MacKichan JJ; Mohrland JS; Wolf DL; Leier CV Clin Pharmacol Ther; 1992 Nov; 52(5):496-503. PubMed ID: 1424424 [TBL] [Abstract][Full Text] [Related]
57. Effect of low grade exercise training and a vasodilator on cardiac function in patients with recent myocardial infarction. Yokota M; Tsuzuki J; Inagaki H; Watanabe M; Matsunami T; Sotobata I Jpn Circ J; 1990 Nov; 54(11):1426-9. PubMed ID: 2149573 [No Abstract] [Full Text] [Related]
58. Systemic ulcerative lesions in a patient with ischemic heart disease. Nikaido M; Miyamoto S; Iinuma S Gastroenterology; 2014 Dec; 147(6):e7-8. PubMed ID: 25450090 [No Abstract] [Full Text] [Related]